3′-Azido-3′-deoxythymidine reduces the rate of transferrin receptor endocytosis in K562 cells
- 8 July 1999
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1450 (3) , 232-241
- https://doi.org/10.1016/s0167-4889(99)00073-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Serum Ferritin, Desferrioxamine, and Evolution of HIV-1 Infection in Thalassemic PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Iron overload in multiply transfused patients who are HIV seropositive.Journal of Clinical Pathology, 1993
- Azidothymidine(AZT)‐induced siderosisAmerican Journal of Hematology, 1993
- Hepatomegaly with severe steatosis in HIV-seropositive patientsAIDS, 1993
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasmCell, 1988
- Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.Proceedings of the National Academy of Sciences, 1987
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- Effects of 2′,3′‐dideoxynucleosides on mammalian cells and virusesJournal of Cellular Physiology, 1984